Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

163.79 +0.39 (+0.24%)
Streaming Delayed Price Updated: 12:06 PM EST, Feb 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,162,572
Open 163.30
Bid (Size) 163.76 (10)
Ask (Size) 163.79 (1)
Prev. Close 163.40
Today's Range 162.90 - 164.15
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.47%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.
Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) 
Via SBWire
This Could Cost Johnson & Johnson Billions in Profit
The talc lawsuits create some risk for the business -- but is it enough of a reason to stay away from the stock? 
Via The Motley Fool

Performance

YTD
-8.08%
-8.08%
1 Month
-6.71%
-6.71%
3 Month
-5.78%
-5.78%
6 Month
-3.75%
-3.75%
1 Year
-4.25%
-4.25%

More News

Read More
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions
Via The Motley Fool
Is It Time to Buy the Dow Jones' 3 Worst-Performing January Stocks?
Via The Motley Fool
The 3 Best Forever Stocks to Buy for February 2023
Via InvestorPlace
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
Via The Motley Fool
1 Resilient Blue Chip Stock to Buy on the Dip
Via The Motley Fool
2 Stocks Down More Than 6% to Buy Right Now
Via The Motley Fool
Johnson & Johnson's Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder
Via Benzinga
Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?
Via InvestorPlace
Johnson & Johnson's Latest Talcum Powder Development Could Be Costly
Via The Motley Fool
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
Via Benzinga
3 Unstoppable Dividend Stocks to Buy in February
Via The Motley Fool
MarketBeat Week in Review – 1/30 - 2/3
Via MarketBeat
Topics Artificial Intelligence Earnings Economy
Exposures Artificial Intelligence Financial Interest Rates
3 Dow Stocks That Make for Screaming Buys in February
Via The Motley Fool
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
From Johnson & Johnson
Via Business Wire
Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029
Via SBWire
Exposures COVID-19
Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst
Via Benzinga
3 Defensive Stocks to Buy If You Think the Market Is Headed Lower
Via InvestorPlace
Looking for a Reliable Dividend Payer? Consider Buying This Blue-Chip Stock
Via The Motley Fool
3 Dividend Stocks to Buy in 2023 for a Lifetime of Passive Income
Via The Motley Fool
Is Johnson & Johnson Stock Worth Buying on the Dip?
Via The Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
Via The Motley Fool
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
Via Newswire.com
How Do Lawsuits Affect Johnson & Johnson's Stock Price?
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.